Expression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma: Its relationship with prognosis

International Journal of Cancer

Volumn 84, Issue 3, 1999, Pages 251-257

  Sagara, Mitsuhisa ^a   Yonezawa, Suguru ^a   Nagata, Koji ^a   Tezuka, Yoshihisa ^a   Natsugoe, Shoji ^a   Xing, Pei Xiang ^b   Mckenzie, Ian F C ^b   Aikou, Takashi ^a   Sato, Eiichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

CA-15-3 ANTIGEN; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HUMANS; PROGNOSIS; SURVIVAL RATE;

EID: 0032992349     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990621)84:3<251::AID-IJC9>3.0.CO;2-7     Document Type: Article

References (49)

1. ABE, M. and KUFE, D., Characterization of cis-acting elements regulating transcription of the human DF3 breast carcinoma-associated antigen (MUC1) gene. Proc. nat. Acad. Sci. (Wash.), 90, 282-286 (1993).
2. BOBEK, L.A., TASAI, H., BIESBROCK, A.R. and LEVINE, M.J., Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J. biol. Chem., 268, 20563-20569 (1993).
3. BONAVINA, L., RUOL, A., ANCONA, E. and PERACCHIA, A., Prognosis of early squamous cell carcinoma of the esophagus after surgical therapy. Dis. Esophagus, 10, 162-164 (1997).
4. BURCHELL, J. and TAYLOR-PAPADIMITRIOU, J., Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product. Epith. Cell Biol., 2, 155-162 (1993).
5. CARRAWAY, K.L. and FREGIEN, N., Mucin structure and function: insights from molecular biology. Glycosci. Glycotechnol., 33, 31-44 (1995).
6. D'CRUZ, O.J., HAAS, G., DUNN, T.S., SACHDEV, G.P. and PICHAN, P., Antigenic cross-reactivity of human tracheal mucin with human sperm and trophoblasts correlates with the expression of mucin 8 gene messenger ribonucleic acid in reproductive tract tissues. Fertil. Steril., 66, 316-326 (1996).
7. DILULIA, N.A., YAMAKAMI, K. and WASHINGTON, S., Effect of long-term culture of a human laryngeal carcinoma cell line on epitectin production and tumorigenicity in athymic mice. Glycosyl. Dis., 1, 21-30 (1994).
8. GENDLER, S.J., LANCASTER, C.A., TAYLOR-PAPADIMITRIOU, J., DUHIG, T., PEAT, N., BURCHELL, J., PEMBERTON, L., LALANI, E.N., and WILSON, D., Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. biol. Chem., 265, 15286-15293 (1990).
9. GOSEKI, N., KOIKE, M. and YOSHIDA, M., Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer, 69, 1088-1093 (1992).
10. GUM, J.R., BYRD, J.C., HICKS, J.W., TORIBARA, N.W., LAMPORT, D.T.A. and KIM, Y.S., Molecular cloning of human intestinal mucin cDNAs: sequence analysis and evidence for genetic polymorphism. J. biol Chem., 264, 6480-6487 (1989).
11. GUM, J.R., HICKS, J.W., SWALLOW, D.M., LAGACE, R.L., BYRD, J.C., LAMPORT, D.T.A., SIDDIKI, B. and KIM, Y.S., Molecular cloning of cDNA derived from a novel human intestinal mucin gene. Biochem. biophys. Res. Commun., 71, 407-415 (1990).
12. HAYES, D.F., SEKINE, H., OHNO, T., ABE, M., KEEFE, K. and KUFE, D.W., Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast-cancer patients. J. clin. Invest., 75, 1671-1678 (1985).
13. Hsu, S.M., GAINE, L. and FANGER, H., Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J. Histochem. Cytochem., 29, 577-580 (1981).
14. IKEDA, Y., KUWANO, H., BABA, K., IKEBE, M., MATUSHIMA, T., ADACHI, Y., MORI, M. and SUGIMACHI, K., Expression of Sialyl-Tn antigens in normal squamous epithelium, dysplasia and squamous-cell carcinoma in the esophagus. Cancer Res., 53, 1706-1708 (1993).
15. IKEDA, Y., KUWANO, H., IKEBE, M., BABA, K., TOH, Y., ADACHI, Y. and SUGIMACHI, K., Immunohistochemical detection of CEA, CA19-9, and DF3 in esophageal carcinoma limited to the submucosal layer. J. surg. Oncol., 56, 7-12 (1994).
16. IRIMURA, T., MCISAAC, A.M., CARLSON, D.A., YAGITA, M., GRIMM, E.A., MENTER, D., OTA, D.M. and CLEARY, K.R., Soluble factor in normal tissues that stimulates high-molecular-weight sialoglycoprotein produced by human colon-carcinoma cells. Cancer Res., 50, 3331-3338 (1990).
17. x antigens. Semin. Cancer Biol., 4, 319-324 (1993).
18. ITZKOWITZ, S.H., YUAN, M., MONTGOMERY, C.K., KJELDSEN, T., TAKAHASHI, H.K., BIGBEE, W.L. and KIM, Y.S., Expression of Tn, Sialosyl-Tn, and T antigens in human colon cancer. Cancer Res., 49, 197-204 (1989).
19. JAPANESE SOCIETY FOR ESOPHAGEAL DISEASE, Guidelines for clinical and pathological studies on carcinoma of the esophagus (8th ed.), p. 45, Kanehara, Tokyo (1992).
20. KIM, Y.S., Mucin glycoproteins in gastrointestinal malignancies and metastasis. Europ. J. Gastroenterol. Hepatol., 5, 219-225 (1993).
21. KITAMURA, H., YONEZAWA, S., TANAKA, S., KIM, Y.S. and SATO, E., Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: their relationship to prognosis. Jap. J. Cancer Res., 87, 631-640 (1996).
22. KJELDSEN, T., CLAUSEN, H., HIROHASHI, S., OGAWA, T., IIJIMA, H. and HAKOMORI, S., Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6α-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res., 48, 2214-2220 (1988).
23. KUFE, D., INGHIRAMI, G., ABE, M., HAYES, D., JUSTI-WHEELER, H. and SCHLOM, J., Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma, 3, 223-232 (1984).
24. LAN, M.S., BATRA, S.K., QI, W., METZGER, R.S. and HOLLINGSWORTH, M.A., Cloning and sequencing of a human pancreatic mucin cDNA. J. biol. Chem., 265, 15294-15299 (1990).
25. LAPENSEE, L., PAQUETTE, Y. and BLEAU, G., Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9). Fertil. Steril., 68, 702-708 (1997).
26. LIGTENBERG, M.J.L., BUIJS, F., VOS, H.L. and HILKENS, J., Suppression of cellular aggregation by high level of episialin. Cancer Res., 52, 2318-2324 (1992).
27. MAKIGUCHI, Y., HINODA, Y. and IMAI, K., Effect of MUC1 mucin and anti-adhesion molecule on tumor-cell growth. Jap. J. Cancer Res., 87, 505-511 (1996).
28. MEERZAMAN, D., CHARLES, P., DASKAL, E., POLYMEROPOULOS, M.H., MARTIN, B.M. and ROES, M.C., Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5). J. biol. Chem., 269, 12932-12939 (1994).
29. MORIARTY, J., SKELLY, C.M., BHARATHAN, S., MOODY, C.E. and SHERBLOM, A.P., Sialomucin and lytic susceptibility of rat mammary tumor ascites cells. Cancer Res., 50, 6800-6805 (1990).
30. OGATA, S., MAIMONIS, P.J. and ITZKOWITZ, S.H., Mucins bearing the cancer-associated sialosyl-Tn antigen-mediated inhibition of natural killer cell cytotoxicity. Cancer Res., 52, 4741-4746 (1992).
31. OSAKO, M., YONEZAWA, S., SIDDIKI, B., HUANG, J., HO, J.J.L., KIM, Y.S. and SATO, E., Immunohistochemical study of mucin carbohydrates and core protein in human pancreatic tumors. Cancer, 71, 2191-2199 (1993).
32. PEREY, L., HAYES, D.F., MAIMONIS, P., ABE, M., O'HARA, C. and KUFE, D.W., Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen. Cancer Res., 52, 2563-2568 (1992).
33. PORCHET, N., VAN CONG, N., DUFOSSE, J., AUDIE, J.P., GUYONNET-DUPERAT, V., GROSS, M.S., DENIS, C., DEGAND, P., BERNHEIM, A. and AUBERT, J.P., Molecular cloning and chromosomal localization of novel human tracheobronchial mucin cDNA containing tandemly repeated sequence of 48 base pairs. Biochem. biophys. Res. Commun., 175, 414-422 (1991).
34. RINSUM, J.V., SMETS, L.A., ROOY, H.V. and VAN DEN EIJNDEN, D.H., Specific inhibition of human natural killer cell-mediated cytotoxicity by sialic acid and sialooligosaccharides. Int. J. Cancer, 38, 915-922 (1986).
35. SIDDIQUI, J., ABE, M., HAYES, D., SHANI, E., YUNIS, E. and KUFE, D., Isolation and sequencing of a cDNA coding for the human DF3 breast-carcinoma-associated antigen. Proc. not. Acad. Sci. (Wash.), 85, 2320-2323 (1988).
36. SUGIMACHI, K., OHNO, S., MATSUDA, H., MORI, H. and KUWANO, H., Clinicopathologic study of early stage esophageal carcinoma, Surgery, 105, 706-710 (1989).
37. SUWA, T., HINODA, Y., MAKIGUCHI, Y., TAKAHASHI, T., ITOH, F., ADACHI, M., HAREYAMA, M. and IMAI, K., Increased invasiveness of MUC1 cDNA-transfected human gastric-cancer MKN74 cells. Int. J. Cancer, 76, 377-382 (1998).
38. SWISHER, S.G., HUNT, K.K., HOLMES, E.C., ZINNER, M.J. and MCFADEEN, D.W., Changes in the surgical management of esophageal cancer from 1970 to 1993. Amer. J. Surg., 169, 609-614 (1995).
39. TACHIBANA, M., YOSHIMURA, H., KINUGASA, S., HASHIMOTO, N., DHAR, D.K., ABE, S., MONDEN, N. and NAGASUE, N., Clinicopathological features of superficial squamous cell carcinoma of the esophagus. Amer. J. Surg., 174, 49-53 (1997).
40. TAKAHASHI, H.K., METOKI, R. and HAKOMORI, S., Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor-associated α-N-acetylgalactosaminyl epitope) that does not cross-react with blood group A antigen. Cancer Res., 48, 4361-4367 (1988).
41. TASHIRO, Y., YONEZAWA, S., KIM, Y.S. and SATO, E., Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors. Hum. Pathol. 25, 364-372 (1994).
42. TORIBARA, N.W., ROBERTON, A.M., HO, S.B., KUO, W., GUM, E., HICKS, J.W., GUM, J.R., BYRD, J.C., SIDDIKI, B. and KIM, Y.S., Human gastric mucin: identification of a unique species by expression cloning. J. biol. Chem., 268, 5879-5885 (1993).
43. UTSUNOMIYA, T., YONEZAWA, S., SAKAMOTO, H., KITAMURA, H., HOKITA, S., AIKO, T., TANAKA, S., IRIMURA, T., KIM, Y.S. and SATO, E., Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with prognosis of the patients. Clin. Cancer Res., 4, 2605-2614 (1998).
44. VAN DE WIEL-VAN KEMENADE, E., LIGTENBERG, M.J.L., DE BORE, A.J., BUIJS, F., VOS, H.L., MELIEF, C.J.M., HILKENS, J. and FIGDOR, C.G., Episialin (MUC1) inhibits cytotoxic lymphocyte-target-cell interaction. J. Immunol., 151, 767-776 (1993).
45. WESSELING, J., VAN DER VALK, S.W., VOS, H.L., SONNENBERG, A. and HILKENS, J., Episialin (MUC1) over-expression inhibits integrin-mediated cell adhesion to extracellular matrix components. J. Cell. Biol., 129, 255-265 (1995).
46. XING, P.-X., PRENZOSKA, J., QUELCH, K., and MCKENZIE, I.F.C., Second generation anti-MUC1 peptide monoclonal antibodies. Cancer Res., 52, 2310-2317 (1992).
47. YAMASHITA, K., YONEZAWA, S., TANAKA, S., SHIRAHAMA, H., SAKODA, K., IMAI, K., XING, P.-X., MCKENZIE, I.F.C., HILKENS, J., KIM, Y.S. and SATO, E., Immunohistochemical study of mucin carbohydrates and core protein in hepatolithiasis and cholangiocarcinoma. Int. J. Cancer, 55, 82-91 (1993).
48. YONEZAWA, S. and SATO, E., Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol. Int., 47, 813-830 (1997).
49. YONEZAWA, S., TACHIKAWA, T., SHIN, S. and SATO, E., Sialosyl-Tn antigen: ils distribution in normal human tissues and expression in adenocarcinomas. Amer. J. clin. Pathol., 98, 167-174 (1992).